LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $766,000 | -25.3% | 240,000 | 0.0% | 99.74% | +0.1% |
| Q1 2022 | $1,025,000 | -8.2% | 240,000 | 0.0% | 99.61% | +0.2% |
| Q4 2021 | $1,116,000 | +16.5% | 240,000 | 0.0% | 99.38% | +0.2% |
| Q3 2021 | $958,000 | -6.7% | 240,000 | 0.0% | 99.17% | +4.3% |
| Q2 2021 | $1,027,000 | +0.9% | 240,000 | 0.0% | 95.09% | +0.3% |
| Q1 2021 | $1,018,000 | +9.3% | 240,000 | 0.0% | 94.79% | +2.2% |
| Q4 2020 | $931,000 | -3.7% | 240,000 | 0.0% | 92.73% | +18.5% |
| Q3 2020 | $967,000 | -5.4% | 240,000 | 0.0% | 78.24% | -1.3% |
| Q2 2020 | $1,022,000 | +1.4% | 240,000 | 0.0% | 79.29% | -1.0% |
| Q1 2020 | $1,008,000 | +6.9% | 240,000 | 0.0% | 80.13% | +617.1% |
| Q4 2019 | $943,000 | -55.4% | 240,000 | 0.0% | 11.17% | -85.1% |
| Q3 2019 | $2,112,000 | -4.9% | 240,000 | 0.0% | 75.03% | -1.1% |
| Q2 2019 | $2,220,000 | +43.9% | 240,000 | 0.0% | 75.87% | +22.7% |
| Q1 2019 | $1,543,000 | – | 240,000 | – | 61.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |